Compare Blackrock Inc (BLK) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Blackrock Inc vs Twist Bioscience Corp — how do they compare? Blackrock Inc trades at $1,145.5 (market cap $177.92B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Blackrock Inc is far larger — about 23× Twist Bioscience Corp's market cap, and Blackrock Inc pays a 2% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| BLK | TWST | |
|---|---|---|
Market Cap | $177.92B | $7.72B |
Volume | 641,547 | — |
Sector | Financials | Health |
52-Week High | $1.20K | $124.88 |
52-Week Low | $922.90 | $24.16 |
Enterprise Value | $179.02B | $7.65B |
Dividend Yield | 2% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Blackrock Inc
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
